For a detailed description of a research project, please reach out!
Team leads: Guy Van Camp, Ken Op de Beeck
Improving diagnostic accuracy and follow-up of neuroendocrine neoplasms through detection of (epi)genetic biomarkers in liquid biopsies using novel technological platforms.
-PhD student: Laura Mariën
Promotors: Guy Van Camp, Ken Op de Beeck, & Marc Peeters, in collaboration with Antwerp NETwerk and Timon Vandamme (Oncology, UZA)
Screening and early detection of colorectal cancer and breast cancer in liquid biopsies using a newly-developed multi-regional methylation assay.
-Dr. Isabelle Neefs, PhD awarded 2024
Improving colorectal cancer detection and treatment follow-up through the development of a novel methylation assay.
-PhD student Katleen Janssens
Promotors: Guy Van Camp, Ken Op de Beeck, Timon Vandamme, & Marc Peeters (Oncology, UZA)
Development of a biomarker test for the screening and treatment response monitoring of malignant pleural mesothelioma.
- Dr. Janah Vandenhoeck, PhD awarded 2024
Tackling delayed diagnosis and therapy resistance in malignant pleural mesothelioma using patient-derived organoids and liquid biopsies.
- PhD student Nele De Meulenaere
Promotors: Guy Van Camp, Ken Op de Beeck & Christophe Deben, in collaboration with Jan Van Meerbeeck (Pneumology, UZA)
Genome-wide Identification of Universal and Type-specific DNA Methylation Markers for the Most Common Cancer Types.
-Postdoc Joe Ibrahim
Bioinformatics analysis of large datasets for detection of genetic and epigenetic tumor signatures of lung and colorectal cancer.
-PhD student: Thomas Vanpoucke
Leveraging patient-driven research to improve rational therapy selection in ROS1+ non-small cell lung cancer (NSCLC).
-PhD students Marc Terrones & Farhan Ul Haq
Promotors: Guy Van Camp, Ken Op de Beeck, Geert Vandeweyer & Patrick Pauwels
Developing a combined screening and molecular triage approach for cervical cancer based on HPV detection, quantification, genotyping and DNA methylation in self-samples.
-PhD student: Eef van den Borst
Promotors: Guy Van Camp, Ken Op de Beeck, & Marc Peeters (Oncology, UZA)
IMPRESS: A novel methylation detection technique combining methylation-sensitive restriction enzymes + single-molecule Molecular Inversion Probes for improving cancer detection.
Patent pending.